Review weighs treatments for genitourinary symptoms of menopause
By
Haymarket Media
Sep 10, 2024
Vaginal estrogen, vaginal DHEA, oral ospemifene and vaginal moisturizers may be beneficial for some genitourinary symptoms.
Behavior change intervention via mail cuts use of sleep medications in older adults
By
HealthDay News
Sep 20, 2024
Older adults with long-term benzodiazepine receptor agonist use and an insomnia diagnosis had significant improvements in sleep outcomes.
Influenza A identified at 11 sites in four states in wastewater testing
By
HealthDay News
Sep 19, 2024
Three of the four states had corresponding evidence of human influenza activity from other surveillance systems.
Stroke was third most common GBD level 3 cause of death in 2021
By
HealthDay News
Sep 20, 2024
There wee 93.8 million prevalent strokes and 11.9 million incident strokes recorded in 2021; disparities were seen in burden by GBD region, country or territory, and sociodemographic index.
Diabetes complications tied to higher risk for gum disease
By
HealthDay News
Sep 19, 2024
The presence of dyslipidemia further increases the odds of having gum disease in those with neuropathy and retinopathy.
Cognitively stimulating leisure activity protects from further cognitive decline
By
HealthDay News
Sep 19, 2024
The optimal level of programming is at least three to four times a week in older adults with mild cognitive impairment.
Racial disparities seen in prehospital stroke care
By
HealthDay News
Sep 18, 2024
The findings were seen despite similar use of emergency medical services transport.
FDA expands use of breast cancer drug Kisqali
By
HealthDay News
Sep 18, 2024
The medication already was approved for advanced disease.
Many US adults with uncontrolled HTN are unaware of HTN status
By
HealthDay News
Sep 13, 2024
70.8%t of those who were aware of their high blood pressure status and met the criteria for meds had uncontrolled hypertension.
Once-weekly efsitora noninferior to degludec for type 2 diabetes
By
HealthDay News
Sep 13, 2024
Once-weekly efsitora was noninferior to once-daily degludec for a decrease in the mean glycated hemoglobin level.